Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,099 JPY | +0.96% | -0.07% | -1.82% |
Feb. 13 | Ezaki Glico's Profit Up 75% in Fiscal 2023 | MT |
Feb. 13 | Ezaki Glico Opposes Shareholder Proposal | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- The stock, which is currently worth 2024 to 0.49 times its sales, is clearly overvalued in comparison with peers.
- The company appears to be poorly valued given its net asset value.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the past twelve months, EPS forecast has been revised upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Most analysts recommend that the stock should be sold or reduced.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.82% | 1.66B | B+ | ||
-2.25% | 95.24B | C+ | ||
+3.76% | 46.64B | C+ | ||
+0.85% | 40.77B | B- | ||
+9.58% | 40.3B | B- | ||
+0.38% | 38.22B | B- | ||
-15.54% | 30.61B | B- | ||
-6.49% | 29.66B | A | ||
+13.81% | 25.09B | A- | ||
-10.87% | 22.26B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 2206 Stock
- Ratings Ezaki Glico Co., Ltd.